Company
Forbion
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Sling Therapeutics | Series C | 2026-09-16 | Lead |
| Expedition Therapeutics | Series B | 2026-08-05 | |
| Memento Medicines | Series A | 2026-06-19 | Lead |
| Slate Medicines | Series A | 2026-02-24 | Lead |
| Altesa BioSciences | Series B | 2026-02-19 | Lead |
| Corsera Health | Series A | 2026-01-07 | Lead |
| Protego Biopharma | Series B | 2025-12-01 | Lead |
| Gate Bioscience | Series B | 2025-11-13 | Lead |
| Braveheart Bio | Series A | 2025-11-05 | |
| Sparrow Pharmaceuticals | Series B | 2025-09-24 | Lead |
| MapLight Therapeutics | Series D | 2025-07-28 | Lead |
| Mosanna Therapeutics | Series A | 2025-06-09 | Lead |
| Navigator Medicines | Series A Financing | 2024-08-27 | Lead |
| Capstan Therapeutics | Series B Financing | 2024-03-21 | |
| Engrail Therapeutics | Series B Financing | 2024-03-19 | Lead |
| Aiolos Bio | Series A Funding | 2023-10-25 | Lead |
| Rampart Bioscience | Series A Financing | 2023-10-24 | Lead |
| Mariana Oncology | Series B Funding | 2023-09-07 | Lead |